Ablation of peroxiredoxin II attenuates experimental colitis by increasing FoxO1-induced Foxp3+ regulatory T cells

Journal of Immunology

Volumn 191, Issue 8, 2013, Pages 4029-4037

  Won, Hee Yeon ^a   Jang, Eun Jung ^a   Lee, Kihyun ^a   Oh, Sera ^a   Kim, Hyo Kyung ^a   Woo, Hyun Ae ^a   Kang, Sang Won ^a   Yu, Dae Yeul ^b   Rhee, Sue Goo ^a   Hwang, Eun Sook ^a  

^a Ewha Womans University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; GAMMA INTERFERON; INTERLEUKIN 17; PEROXIREDOXIN 2; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; ENZYME INACTIVATION; FOXP3 GENE; GENE REPRESSION; IN VITRO STUDY; IN VIVO STUDY; MORTALITY; MOUSE; NONHUMAN; OXIDATION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN STABILITY; REGULATORY T LYMPHOCYTE; TRANSCRIPTION INITIATION; UPREGULATION; WEIGHT REDUCTION;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; DEXTRAN SULFATE; FORKHEAD TRANSCRIPTION FACTORS; INTERFERON-GAMMA; INTERLEUKIN-17; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEROXIREDOXINS; PROTO-ONCOGENE PROTEINS C-MDM2; REACTIVE OXYGEN SPECIES; T-LYMPHOCYTES, REGULATORY;

EID: 84885446113     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203247     Document Type: Article

References (47)

1. D'Autréaux, B., and M. B. Toledano. 2007. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 8: 813-824.
2. Perricone, C., C. De Carolis, and R. Perricone. 2009. Glutathione: a key player in autoimmunity. Autoimmun. Rev. 8: 697-701.
3. Rhee, S. G., K. S. Yang, S. W. Kang, H. A. Woo, and T. S. Chang. 2005. Controlled elimination of intracellular H2O2: regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification. Antioxid. Redox Signal. 7: 619-626.
4. Veal, E., and A. Day. 2011. Hydrogen peroxide as a signaling molecule. Antioxid. Redox Signal. 15: 147-151.
5. Rhee, S. G., S. W. Kang, W. Jeong, T. S. Chang, K. S. Yang, and H. A. Woo. 2005. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr. Opin. Cell Biol. 17: 183-189.
6. Kang, S. W., I. C. Baines, and S. G. Rhee. 1998. Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. J. Biol. Chem. 273: 6303-6311.
7. Hofmann, B., H. J. Hecht, and L. Flohé. 2002. Peroxiredoxins. Biol. Chem. 383: 347-364.
8. Wood, Z. A., L. B. Poole, and P. A. Karplus. 2003. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300: 650-653.
9. Kang, S. W., S. G. Rhee, T. S. Chang, W. Jeong, and M. H. Choi. 2005. 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends Mol. Med. 11: 571-578.
10. Cox, A. G., C. C. Winterbourn, and M. B. Hampton. 2010. Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem. J. 425: 313-325.
11. Neumann, C. A., D. S. Krause, C. V. Carman, S. Das, D. P. Dubey, J. L. Abraham, R. T. Bronson, Y. Fujiwara, S. H. Orkin, and R. A. Van Etten. 2003. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424: 561-565.
12. Lee, T. H., S. U. Kim, S. L. Yu, S. H. Kim, D. S. Park, H. B. Moon, S. H. Dho, K. S. Kwon, H. J. Kwon, Y. H. Han, et al. 2003. Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood 101: 5033-5038.
13. Yang, C. S., D. S. Lee, C. H. Song, S. J. An, S. Li, J. M. Kim, C. S. Kim, D. G. Yoo, B. H. Jeon, H. Y. Yang, et al. 2007. Roles of peroxiredoxin II in the regulation of proinflammatory responses to LPS and protection against endotoxin-induced lethal shock. J. Exp. Med. 204: 583-594.
14. Park, J. G., J. Y. Yoo, S. J. Jeong, J. H. Choi, M. R. Lee, M. N. Lee, J. Hwa Lee, H. C. Kim, H. Jo, D. Y. Yu, et al. 2011. Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice. Circ. Res. 109: 739-749.
15. Moon, E. Y., Y. W. Noh, Y. H. Han, S. U. Kim, J. M. Kim, D. Y. Yu, and J. S. Lim. 2006. T lymphocytes and dendritic cells are activated by the deletion of peroxiredoxin II (Prx II) gene. Immunol. Lett. 102: 184-190.
16. Moon, E. Y., J. S. Kang, S. H. Han, K. H. Yang, S. Pyo, M. Y. Lee, H. K. Lee, and D. Y. Yu. 2008. Differential role of peroxiredoxin II (PrxII) on the expression of Toll-like receptor 4 (TLR4) and B-cell activating factor (BAFF) in ovalbumin (OVA)-induced mouse asthma. Int. Immunopharmacol. 8: 935-944.
17. Segal, A. W., I. West, F. Wientjes, J. H. Nugent, A. J. Chavan, B. Haley, R. C. Garcia, H. Rosen, and G. Scrace. 1992. Cytochrome b-245 is a flavocytochrome containing FAD and the NADPH-binding site of the microbicidal oxidase of phagocytes. Biochem. J. 284: 781-788.
18. Vazquez-Torres, A., J. Jones-Carson, P. Mastroeni, H. Ischiropoulos, and F. C. Fang. 2000. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J. Exp. Med. 192: 227-236.
19. Williams, M. S., and J. Kwon. 2004. T cell receptor stimulation, reactive oxygen species, and cell signaling. Free Radic. Biol. Med. 37: 1144-1151.
20. Jackson, S. H., S. Devadas, J. Kwon, L. A. Pinto, and M. S. Williams. 2004. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat. Immunol. 5: 818-827.
21. Williams, M. S., and P. A. Henkart. 1996. Role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas. J. Immunol. 157: 2395-2402.
22. Hildeman, D. A., T. Mitchell, T. K. Teague, P. Henson, B. J. Day, J. Kappler, and P. C. Marrack. 1999. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10: 735-744.
23. Devadas, S., L. Zaritskaya, S. G. Rhee, L. Oberley, and M. S. Williams. 2002. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-Activated protein kinase activation and fas ligand expression. J. Exp. Med. 195: 59-70.
24. Won, H. Y., J. H. Sohn, H. J. Min, K. Lee, H. A. Woo, Y. S. Ho, J. W. Park S. G. Rhee, and E. S. Hwang. 2010. Glutathione peroxidase 1 deficiency attenuates allergen-induced airway inflammation by suppressing Th2 and Th17 cell development. Antioxid. Redox Signal. 13: 575-587.
25. Won, H. Y., E. J. Jang, H. J. Min, and E. S. Hwang. 2011. Enhancement of allergeninduced airway inflammation by NOX2 deficiency. Immune Netw. 11: 169-174.
26. Lee, K., H. Y. Won, M. A. Bae, J. H. Hong, and E. S. Hwang. 2011. Spontaneous and aging-dependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b+ and Th/Treg cells. Proc. Natl. Acad. Sci. USA 108: 9548-9553.
27. Berberat, P. O., Y. I. A-Rahim, K. Yamashita, M. M. Warny, E. Csizmadia, S. C. Robson, and F. H. Bach. 2005. Heme oxygenase-1-generated biliverdin ameliorates experimental murine colitis. Inflamm. Bowel Dis. 11: 350-359.
28. Kim, H. P., and W. J. Leonard. 2007. CREB/ATF-dependent T cell receptorinduced FoxP3 gene expression: a role for DNA methylation. J. Exp. Med. 204: 1543-1551.
29. Jang, E. J., H. R. Park, J. H. Hong, and E. S. Hwang. 2013. Lysine 313 of T-box is crucial for modulation of protein stability, DNA binding, and threonine phosphorylation of T-bet. J. Immunol. 190: 5764-5770.
30. Ivanov, I. I., B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua, and D. R. Littman. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
31. Zhou, L., M. M. Chong, and D. R. Littman. 2009. Plasticity of CD4+ T cell lineage differentiation. Immunity 30: 646-655.
32. Hwang, E. S. 2010. Transcriptional regulation of T helper 17 cell differentiation. Yonsei Med. J. 51: 484-491.
33. Eckerstorfer, P., M. Novy, S. Burgstaller-Muehlbacher, W. Paster, H. B. Schiller, H. Mayer, and H. Stockinger. 2010. Proximal human FOXP3 promoter transactivated by NF-kappaB and negatively controlled by feedback loop and SP3. Mol. Immunol. 47: 2094-2102.
34. Harada, Y., Y. Harada, C. Elly, G. Ying, J. H. Paik, R. A. DePinho, and Y. C. Liu. 2010. Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J. Exp. Med. 207: 1381-1391.
35. Kerdiles, Y. M., E. L. Stone, D. R. Beisner, M. A. McGargill, I. L. Ch'en, C. Stockmann, C. D. Katayama, and S. M. Hedrick. 2010. Foxo transcription factors control regulatory T cell development and function. Immunity 33: 890-904.
36. Ouyang, W., O. Beckett, Q. Ma, J. H. Paik, R. A. DePinho, and M. O. Li. 2010. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat. Immunol. 11: 618-627.
37. Samstein, R. M., A. Arvey, S. Z. Josefowicz, X. Peng, A. Reynolds, R. Sandstrom, S. Neph, P. Sabo, J. M. Kim, W. Liao, et al. 2012. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151: 153-166.
38. Podolsky, D. K. 1991. Inflammatory bowel disease (2). N. Engl. J. Med. 325: 1008-1016.
39. Fuss, I. J., M. Neurath, M. Boirivant, J. S. Klein, C. de la Motte, S. A. Strong, C. Fiocchi, and W. Strober. 1996. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease: Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 157: 1261-1270.
40. Kaser, A., S. Zeissig, and R. S. Blumberg. 2010. Inflammatory bowel disease. Annu. Rev. Immunol. 28: 573-621.
41. Fujino, S., A. Andoh, S. Bamba, A. Ogawa, K. Hata, Y. Araki, T. Bamba, and Y. Fujiyama. 2003. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70.
42. Khan, W. I., Y. Motomura, H. Wang, R. T. El-Sharkawy, E. F. Verdu M. Verma-Gandhu, B. J. Rollins, and S. M. Collins. 2006. Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G803-G811.
43. Leppkes, M., C. Becker, I. I. Ivanov, S. Hirth, S. Wirtz, C. Neufert, S. Pouly, A. J. Murphy, D. M. Valenzuela, G. D. Yancopoulos, et al. 2009. RORgammaexpressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 136: 257-267.
44. Murray, P. J., and T. A. Wynn. 2011. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11: 723-737.
45. Obsil, T., and V. Obsilova. 2008. Structure/function relationships underlying regulation of FOXO transcription factors. Oncogene 27: 2263-2275.
46. Essers, M. A., S. Weijzen, A. M. de Vries-Smits, I. Saarloos, N. D. de Ruiter, J. L. Bos, and B. M. Burgering. 2004. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 23: 4802-4812.
47. Fu, W., Q. Ma, L. Chen, P. Li, M. Zhang, S. Ramamoorthy, Z. Nawaz, T. Shimojima, H. Wang, Y. Yang, et al. 2009. MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation. J. Biol. Chem. 284: 13987-14000.